top of page

BioIntelliSense

More About the Company

Status:

Technology Type:

Exited

Device

Fund:

Fund I

CU Anschutz Medical Campus Spinout:

No

Headquarters 
Location:

Denver, CO, USA

Remote Patient Monitoring

BioIntelliSense is ushering in a new era of continuous health monitoring and clinical intelligence for Remote Patient Monitoring (RPM). Its medical-grade Data-as-a-Service (DaaS) platform seamlessly captures minute-to-minute vital signs, physiological biometrics and symptomatic events through an effortless patient experience. The FDA-cleared BioStickerâ„¢ device makes remote monitoring and early detection simple. Through the platform's advanced analytics, clinicians will now have access to high-resolution patient trending and reporting to enable medical grade care in the home.


CU Anschutz and UCHealth are working with BioIntellisense on several projects to enable remote patient monitoring for our patient population

bottom of page